JP2020011058A - Communication member - Google Patents
Communication member Download PDFInfo
- Publication number
- JP2020011058A JP2020011058A JP2019124120A JP2019124120A JP2020011058A JP 2020011058 A JP2020011058 A JP 2020011058A JP 2019124120 A JP2019124120 A JP 2019124120A JP 2019124120 A JP2019124120 A JP 2019124120A JP 2020011058 A JP2020011058 A JP 2020011058A
- Authority
- JP
- Japan
- Prior art keywords
- main body
- axial direction
- communication member
- holes
- vein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Prostheses (AREA)
Abstract
【課題】2つの管腔臓器の連通をより簡便に行う。【解決手段】2つの管腔臓器(例えば、リンパ管L1及び静脈L2)を連通させる連通部材100であって、側部どうしを対向させるように配置された2つの管腔臓器の各管壁を貫通するように留置され、筒状の本体部1を有し、本体部1の外面を管壁の貫通孔L1a、L2aの各々の内面に当接させるようにして貫通孔L1a、L2aの各々に挿通された状態で、本体部1の軸方向及び軸方向と交わる径方向に当該本体部1が位置決めされて留置可能に構成されている。【選択図】図3An object of the present invention is to more easily communicate communication between two hollow organs. A communication member 100 that communicates two luminal organs (for example, a lymphatic vessel L1 and a vein L2), which connects each tube wall of the two luminal organs arranged so that their sides face each other. It is indwelled so as to penetrate through the tube, has a cylindrical main body part 1, and is inserted into each of the through holes L1a and L2a by bringing the outer surface of the main body part 1 into contact with the inner surface of each of the through holes L1a and L2a of the tube wall. In the inserted state, the main body part 1 is positioned in the axial direction of the main body part 1 and in the radial direction crossing the axial direction, and is configured to be indwellable. [Selection diagram] Figure 3
Description
本発明は、連通部材に関する。 The present invention relates to a communication member.
従来、血管やリンパ管などの管腔臓器どうしを吻合して、連通させる手技(例えば、リンパ管静脈吻合術等)が知られている。
管腔臓器どうしの吻合、特に、第1の管腔臓器の端部と第2の管腔臓器の側部との吻合は、施術者に豊富な経験や高い技量が要求されることから、近年、第1の血管の端部と第2の血管の側部とを縫合糸を使用せずに吻合するための血管継手が提案されている(例えば、特許文献1参照)。
2. Description of the Related Art Conventionally, there has been known a technique of anastomosis between luminal organs such as blood vessels and lymph vessels so as to communicate with each other (for example, lymphatic vein anastomosis).
Anastomosis between luminal organs, particularly anastomosis between the end of the first luminal organ and the side of the second luminal organ, requires abundant experience and high skill from the practitioner. A vascular joint for anastomosis between the end of a first blood vessel and the side of a second blood vessel without using a suture has been proposed (for example, see Patent Document 1).
しかしながら、特許文献1に記載の血管継手等の場合、この血管継手の各部を対応する各血管に適正に挿入する必要があるが、当該血管継手のように構造が複雑であると、その操作が難しい。すなわち、第1の管腔臓器の端部と第2の管腔臓器の側部とを吻合させる手技を採用する限り、依然として高い技量が要求されることとなるため、2つの管腔臓器をより簡便に連通させる手法が望まれている。 However, in the case of the vascular joint described in Patent Literature 1, it is necessary to properly insert each part of the vascular joint into each corresponding blood vessel, but if the structure is complicated like the vascular joint, the operation is difficult. difficult. That is, as long as the technique of anastomosis between the end of the first lumen organ and the side of the second lumen organ is employed, a high skill is still required. There is a need for a method of easily communicating.
本発明の目的は、2つの管腔臓器の連通をより簡便に行うことができる連通部材を提供することである。 An object of the present invention is to provide a communication member that can easily communicate two luminal organs.
本発明に係る連通部材は、
2つの管腔臓器を連通させる連通部材であって、
側部どうしを対向させるように配置された前記2つの管腔臓器の各管壁を貫通するように留置され、
筒状の本体部を有し、
前記本体部の外面を前記管壁の貫通孔の各々の内面に当接させるようにして前記貫通孔の各々に挿通された状態で、前記本体部の軸方向及び前記軸方向と交わる方向に当該本体部が位置決めされて留置可能に構成されていることを特徴としている。
The communication member according to the present invention,
A communication member for communicating the two luminal organs,
Indwelled to penetrate each tube wall of the two luminal organs arranged so that the sides face each other,
It has a cylindrical main body,
In a state where the outer surface of the main body is inserted into each of the through holes such that the outer surface of the main body is brought into contact with the inner surface of each of the through holes of the tube wall, the main body is axially and the direction intersecting with the axial direction. The present invention is characterized in that the main body is positioned so as to be placed therein.
本発明によれば、2つの管腔臓器の連通をより簡便に行うことができる。 According to the present invention, communication between two luminal organs can be performed more easily.
以下、本発明の実施形態について図面を参照して説明する。
図1は、本発明に係る一実施形態の連通部材100の使用状態を模式的に示す斜視図である。また、図2(a)及び図2(b)は、連通部材100を拡大して示す図であり、このうち、図2(a)は、連通部材100の斜視図であり、図2(b)は、連通部材100のA−A断面図である。また、図3は、連通部材100の使用状態を拡大して示す正面図である。
Hereinafter, embodiments of the present invention will be described with reference to the drawings.
FIG. 1 is a perspective view schematically showing a use state of a communication member 100 according to an embodiment of the present invention. FIGS. 2A and 2B are enlarged views of the communication member 100. FIG. 2A is a perspective view of the communication member 100, and FIG. () Is an AA cross-sectional view of the communication member 100. FIG. 3 is an enlarged front view showing a use state of the communication member 100.
本実施形態の連通部材100は、例えば、図1に示すように、リンパ浮腫の治療に用いられ、閉塞等によりリンパ液の流れが停滞したリンパ管(第1の管腔臓器)L1と、当該リンパ管L1の近傍の静脈(第2の管腔臓器)L2とを連通させるものである。
具体的には、連通部材100は、図1等に示すように、リンパ管L1と静脈L2の側部(外周面部)どうしを対向させた状態で、これらリンパ管L1及び静脈L2の各管壁を貫通するように留置される。そして、連通部材100によりリンパ管L1と静脈L2とが連通され、リンパ管L1を流れるリンパ液が静脈L2に流入し、血液とともに還流する。
なお、図1及び図3にあっては、リンパ液の流れを一点鎖線で模式的に表し、血液の流れを実線で模式的に表している。
As shown in FIG. 1, for example, the communication member 100 of the present embodiment is used for treatment of lymphedema, and a lymph vessel (first luminal organ) L1 in which the flow of lymph is stagnant due to obstruction or the like, The vein (second luminal organ) L2 near the tube L1 is communicated with the vein L2.
Specifically, as shown in FIG. 1 and the like, the communication member 100 has the lymph vessel L1 and the vein L2 facing each other at their side portions (outer peripheral surfaces), and the wall surfaces of the lymphatic vessel L1 and the vein L2. Is placed so as to penetrate. Then, the lymph vessel L1 and the vein L2 are communicated by the communication member 100, and the lymph fluid flowing through the lymph vessel L1 flows into the vein L2 and returns with the blood.
In FIGS. 1 and 3, the flow of lymph is schematically represented by a dashed line, and the flow of blood is schematically represented by a solid line.
図2(a)及び図2(b)に示すように、連通部材100は、筒状の本体部1と、この本体部1の軸方向における両端部に設けられ、リンパ管L1及び静脈L2の管壁内側面に係合可能な第1及び第2係合部21、22とを備えている。 As shown in FIGS. 2A and 2B, the communication member 100 is provided at both ends of the cylindrical main body 1 in the axial direction of the main body 1, and the communication member 100 is connected to the lymphatic vessel L1 and the vein L2. First and second engaging portions 21 and 22 that can be engaged with the inner surface of the tube wall are provided.
本体部1は、例えば、軸方向の断面が楕円形状を有するとともに、軸方向に所定の長さを有する筒状に形成されている。本体部1の外径、特に、短径は、リンパ管L1及び静脈L2の管壁の貫通孔L1a、L2aの外径よりも大きくなっており、貫通孔L1a、L2aに本体部1が圧入されるようになっている。すなわち、当該連通部材100が貫通孔L1a、L2aの各々に挿通された状態で、本体部1の外面を貫通孔L1a、L2aの各々の内面に周方向の全周にわたって当接させた状態となる。
また、本体部1は、楕円の長軸がリンパ管L1及び静脈L2の軸方向と略平行となるように留置されるのが好ましい。
なお、本体部1の軸方向の断面形状は、一例であって楕円形状に限られるものではなく、例えば、円形状、角形状等に適宜任意に変更可能である。
The main body 1 is, for example, formed in a cylindrical shape having an elliptical cross section in the axial direction and a predetermined length in the axial direction. The outer diameter, particularly the short diameter, of the main body 1 is larger than the outer diameters of the through holes L1a, L2a in the wall of the lymphatic vessel L1 and the vein L2, and the main body 1 is pressed into the through holes L1a, L2a. It has become so. That is, in a state where the communication member 100 is inserted into each of the through holes L1a and L2a, the outer surface of the main body 1 is brought into contact with the inner surface of each of the through holes L1a and L2a over the entire circumference in the circumferential direction. .
The main body 1 is preferably placed so that the major axis of the ellipse is substantially parallel to the axial directions of the lymphatic vessels L1 and veins L2.
The cross-sectional shape in the axial direction of the main body 1 is an example, and is not limited to an elliptical shape, and can be arbitrarily changed to, for example, a circular shape, a square shape, or the like.
また、本体部1は、例えば、図示は省略するが、骨格部が皮膜部で覆われて形成されている。
具体的には、例えば、骨格部は、断面形状が円形又は楕円形の金属細線が山部と谷部とが交互に形成されるように屈曲しながら軸方向に螺旋状に巻回されて形成されている。なお、骨格部は、金属線材を山部と谷部とが交互に形成されるように屈曲しながら円環状に形成した複数の骨格を、軸方向に所定の間隔で配置して形成されてもよい。
また、骨格部は、軸方向に略直交する径方向において、内側に収縮した収縮状態から、外側に拡張して筒状流路を画成する拡張状態へと自己拡張可能に構成されている。
Further, the main body 1 is formed, for example, with a skeleton part covered with a coating part, although not shown.
Specifically, for example, the skeleton portion is formed by winding a thin metal wire having a circular or elliptical cross section in a spiral shape in the axial direction while bending so that peaks and valleys are alternately formed. Have been. Note that the skeleton portion may be formed by arranging a plurality of skeletons formed in an annular shape while bending a metal wire rod so that peak portions and valley portions are formed alternately at predetermined intervals in the axial direction. Good.
The skeletal portion is configured to be self-expandable in a radial direction substantially perpendicular to the axial direction, from a contracted state in which it contracts inward to an expanded state in which it expands outward to define a cylindrical flow path.
骨格部を形成する金属線材の材料としては、例えば、ステンレス鋼、Ni−Ti合金(ニチノール)、チタン合金等に代表される公知の金属又は金属合金が挙げられる。また、X線造影性を有する合金材料を用いてもよい。なお、骨格部は、金属材料以外の材料(例えば、セラミックや樹脂等)で形成されてもよい。
また、骨格部は、例えば、1本の金属パイプ(例えば、Ni−Ti合金からなるパイプ等)をレーザー加工(レーザーカット)することによって形成されてもよい。
Examples of the material of the metal wire forming the skeleton include known metals or metal alloys such as stainless steel, Ni-Ti alloy (Nitinol), and titanium alloy. Further, an alloy material having X-ray contrast may be used. Note that the skeleton may be formed of a material other than the metal material (for example, ceramic or resin).
The skeleton may be formed by, for example, laser processing (laser cutting) a single metal pipe (for example, a pipe made of a Ni—Ti alloy).
皮膜部は、リンパ液の流路を形成する膜体である。皮膜部は、骨格部を挟み込むように、骨格部の外周面及び内周面に配置されてもよいし、骨格部の外周面及び内周面の何れか一方だけに配置されてもよい。 The membrane is a membrane that forms a lymph fluid flow path. The coating portion may be disposed on the outer peripheral surface and the inner peripheral surface of the skeleton portion so as to sandwich the skeleton portion, or may be disposed on only one of the outer peripheral surface and the inner peripheral surface of the skeleton portion.
皮膜部を形成する材料としては、例えば、シリコーン樹脂、PTFE(ポリテトラフルオロエチレン)等のフッ素樹脂、及びポリエチレンテレフタレート等のポリエステル樹脂等が挙げられる。 Examples of a material for forming the film portion include a silicone resin, a fluorine resin such as PTFE (polytetrafluoroethylene), and a polyester resin such as polyethylene terephthalate.
第1及び第2係合部21、22は、軸方向の断面が楕円形状を有するとともに、軸方向に直交する径方向の断面が本体部1に交わるように「八」字状に拡径された形状をなしている(図2(a)及び図2(b)等参照)。
また、第1及び第2係合部21、22は、本体部1の骨格部と同様に、軸方向に略直交する径方向において、内側に収縮した収縮状態から、外側に拡張して筒状流路を画成する拡張状態へと自己拡張可能に構成されている。
The first and second engaging portions 21 and 22 have an elliptical cross section in the axial direction, and are expanded in an “eight” shape such that a radial cross section orthogonal to the axial direction intersects the main body 1. (See FIG. 2A and FIG. 2B).
The first and second engaging portions 21 and 22 are expanded in the radial direction substantially perpendicular to the axial direction from the contracted state contracted inward to the outside in the same manner as the skeletal portion of the main body 1. It is configured to be self-expandable to an expanded state defining a flow path.
また、第1及び第2係合部21、22は、例えば、図示は省略するが、断面形状が円形又は楕円形の金属細線が網目状に編み込まれて形成されている。
第1及び第2係合部21、22を形成する金属線材の材料としては、例えば、本体部1の骨格部と同様に、ステンレス鋼、Ni−Ti合金(ニチノール)、チタン合金等に代表される公知の金属又は金属合金が挙げられる。また、X線造影性を有する合金材料を用いてもよい。なお、骨格部は、金属材料以外の材料(例えば、セラミックや樹脂等)で形成されてもよい。
なお、第1及び第2係合部21、22は、例えば、1本の金属パイプ(例えば、Ni−Ti合金からなるパイプ等)をレーザー加工(レーザーカット)することによって形成されてもよい。
Further, the first and second engaging portions 21 and 22 are formed by, for example, omitting the illustration, a thin metal wire having a circular or elliptical cross-section woven in a mesh shape.
The material of the metal wire forming the first and second engaging portions 21 and 22 is represented by, for example, stainless steel, a Ni—Ti alloy (Nitinol), a titanium alloy, and the like, like the skeleton of the main body 1. Known metal or metal alloy. Further, an alloy material having X-ray contrast may be used. Note that the skeleton may be formed of a material other than the metal material (for example, ceramic or resin).
The first and second engagement portions 21 and 22 may be formed by, for example, laser processing (laser cutting) a single metal pipe (for example, a pipe made of a Ni—Ti alloy).
また、第1及び第2係合部21、22は、当該連通部材100がリンパ管L1及び静脈L2の管壁の貫通孔L1a、L2aの各々に挿通された状態で、管壁内側面における貫通孔L1a、L2aの周縁部に係合する。
すなわち、第1及び第2係合部21、22の基端部の外径、特に、短径は、リンパ管L1及び静脈L2の管壁の貫通孔L1a、L2aの外径よりも大きくなっている。そして、貫通孔L1a、L2aに第1及び第2係合部21、22の基端部が圧入され、第1及び第2係合部21、22の基端部の外面を貫通孔L1a、L2aの各々の軸方向両端部の内面に周方向の全周にわたって当接させた状態となる。また、第1及び第2係合部21、22の先端部の外径は、リンパ管L1及び静脈L2の管壁の貫通孔L1a、L2aの外径よりも大きくなっており、これら第1及び第2係合部21、22により抜け止めされた状態で連通部材100が留置される。
Further, the first and second engagement portions 21 and 22 pass through the inner surface of the tube wall in a state where the communication member 100 is inserted into the through holes L1a and L2a of the tube walls of the lymphatic vessel L1 and the vein L2. It engages with the periphery of the holes L1a, L2a.
That is, the outer diameters, particularly the short diameters, of the proximal ends of the first and second engaging portions 21 and 22 are larger than the outer diameters of the through holes L1a and L2a in the wall of the lymphatic vessel L1 and the vein L2. I have. Then, the base ends of the first and second engagement portions 21 and 22 are press-fitted into the through holes L1a and L2a, and the outer surfaces of the base ends of the first and second engagement portions 21 and 22 are inserted into the through holes L1a and L2a. Are brought into contact with the inner surfaces of both ends in the axial direction over the entire circumference in the circumferential direction. The outer diameters of the distal ends of the first and second engaging portions 21 and 22 are larger than the outer diameters of the through holes L1a and L2a in the wall of the lymphatic vessel L1 and the vein L2. The communication member 100 is retained in a state where the communication member 100 is prevented from falling off by the second engagement portions 21 and 22.
このように、当該連通部材100がリンパ管L1及び静脈L2の管壁の貫通孔L1a、L2aの各々に挿通された状態で、本体部1の軸方向及び軸方向と交わる方向(径方向)に当該本体部1が位置決めされて留置可能に構成されている。 As described above, in a state where the communication member 100 is inserted into each of the through-holes L1a and L2a in the wall of the lymphatic vessel L1 and the vein L2, in the axial direction of the main body 1 and in the direction (radial direction) intersecting with the axial direction. The main body 1 is positioned so that it can be placed.
次に、連通部材100の留置方法について説明する。
先ず、リンパ管L1及び静脈L2の側部の対向する部分に貫通孔L1a、L2aを形成する。貫通孔L1a、L2aは、例えば、リンパ管L1及び静脈L2の管壁を切開することで形成される。
そして、保持具(図示略)に保持され、径方向に縮径された状態の連通部材100の第1係合部21をリンパ管L1の貫通孔L1a内に挿入するとともに、第2係合部22を静脈L2の貫通孔L2a内に挿入する。この状態で、連通部材100が径方向に自己拡張することで、貫通孔L1a、L2aを押し広げるように本体部1が留置され、貫通孔L1a、L2aの周縁部に第1及び第2係合部21、22が係合される。
これにより、連通部材100が留置され、連通部材100によりリンパ管L1及び静脈L2が連通される。
Next, a method of placing the communication member 100 will be described.
First, through holes L1a and L2a are formed in opposing portions of the side of the lymphatic vessel L1 and the vein L2. The through holes L1a and L2a are formed by, for example, incising the wall of the lymphatic vessel L1 and vein L2.
Then, the first engaging portion 21 of the communication member 100 held by a holder (not shown) and reduced in diameter in the radial direction is inserted into the through hole L1a of the lymphatic vessel L1, and the second engaging portion is inserted. 22 is inserted into the through hole L2a of the vein L2. In this state, the communication member 100 self-expands in the radial direction, whereby the main body 1 is retained so as to push and expand the through holes L1a, L2a, and the first and second engagements are formed on the peripheral edges of the through holes L1a, L2a. The parts 21, 22 are engaged.
As a result, the communication member 100 is indwelled, and the communication member 100 communicates the lymphatic vessel L1 and the vein L2.
なお、上記した連通部材100の留置方法は、一例であってこれに限られるものではなく、適宜任意に変更可能である。 The method of placing the communication member 100 described above is an example and is not limited to this, and can be arbitrarily changed as appropriate.
以上のように、本実施形態の連通部材100は、2つの管腔臓器(例えば、リンパ管L1及び静脈L2)を連通させる連通部材100であって、側部どうしを対向させるように配置された2つの管腔臓器の各管壁を貫通するように留置され、筒状の本体部1を有し、本体部1の外面を管壁の貫通孔L1a、L2aの各々の内面に当接させるようにして貫通孔L1a、L2aの各々に挿通された状態で、本体部1の軸方向及び軸方向と交わる径方向に当該本体部1が位置決めされて留置可能に構成されている。
したがって、連通部材100を本体部1の外面を管壁の貫通孔L1a、L2aの各々の内面に当接させるように留置するだけで2つの管腔臓器(例えば、リンパ管L1及び静脈L2)を連通させることができる。特に、本体部1を軸方向及び径方向に位置決めして当該連通部材100を留置することができる。具体的には、リンパ管L1及び静脈L2の管壁の貫通孔L1a、L2aの各々に挿通された状態で、管壁内側面における貫通孔L1a、L2aの周縁部に第1及び第2係合部21、22を係合させて、本体部1を軸方向及び径方向に位置決めすることができる。
このように、第1の管腔臓器(例えば、リンパ管L1)の端部と第2の管腔臓器(例えば、静脈L2)の側部とを吻合する場合に比べて、これら2つの管腔臓器の連通をより簡便に行うことができる。
As described above, the communication member 100 according to the present embodiment is the communication member 100 that allows two luminal organs (for example, the lymphatic vessel L1 and the vein L2) to communicate with each other, and is arranged so that the sides are opposed to each other. It has a tubular main body 1 that is indwelled so as to penetrate each of the tube walls of the two luminal organs, and the outer surface of the main body 1 is brought into contact with the inner surfaces of the through holes L1a and L2a of the tube wall. The main body 1 is positioned in the axial direction of the main body 1 and in a radial direction intersecting with the axial direction in a state where the main body 1 is inserted into each of the through holes L1a and L2a.
Therefore, two luminal organs (for example, the lymphatic vessel L1 and the vein L2) can be formed simply by placing the communicating member 100 such that the outer surface of the main body 1 is in contact with the inner surfaces of the through holes L1a and L2a of the vessel wall. Can communicate. In particular, the communication member 100 can be placed while the main body 1 is positioned in the axial direction and the radial direction. Specifically, the first and second engagements are formed on the inner peripheral surfaces of the through holes L1a and L2a on the inner surface of the tube wall while being inserted through the through holes L1a and L2a of the tube walls of the lymphatic vessel L1 and the vein L2. The main body 1 can be positioned in the axial direction and the radial direction by engaging the parts 21 and 22.
Thus, compared to the case where the end of the first luminal organ (for example, lymphatic vessel L1) and the side of the second luminal organ (for example, vein L2) are anastomosed, these two lumens are compared. The communication of organs can be performed more easily.
以上、本発明者によってなされた発明を実施の形態に基づいて具体的に説明したが、本発明は上記実施の形態に限定されるものではなく、その要旨を逸脱しない範囲で変更可能である。 As described above, the invention made by the inventor has been specifically described based on the embodiment. However, the present invention is not limited to the above embodiment, and can be changed without departing from the gist of the invention.
以下に、本発明に係る連通部材100の変形例について、図4を参照して説明する。連通部材100の変形例は、以下に説明する以外の点で、上記実施形態と略同様であり、その詳細な説明は省略する。 Hereinafter, a modified example of the communication member 100 according to the present invention will be described with reference to FIG. The modification of the communication member 100 is substantially the same as the above embodiment except for the points described below, and a detailed description thereof will be omitted.
図4は、本変形例の連通部材200の使用状態を拡大して示す正面図である。
図4に示すように、連通部材200は、上記実施形態の連通部材100と同様に、筒状の本体部201と、この本体部201の軸方向における両端部に設けられた第1及び第2係合部221、222とを備えている。
FIG. 4 is an enlarged front view showing a use state of the communication member 200 of the present modified example.
As shown in FIG. 4, similarly to the communication member 100 of the above-described embodiment, the communication member 200 includes a cylindrical main body 201 and first and second main bodies 201 provided at both ends in the axial direction of the main body 201. There are provided engaging portions 221 and 222.
本体部201は、上記実施形態の連通部材100の本体部1よりも軸方向の長さが短くされている。具体的には、本体部201の軸方向の長さは、リンパ管L1及び静脈L2の管壁どうしを加算した長さよりもわずかに長くされている。これにより、リンパ管L1と静脈L2の側部どうしをほぼ当接させた状態で保持可能となっている。
また、本体部201は、貫通孔L1a、L2aに圧入され、当該本体部201の拡張力により本体部201の軸方向及び軸方向と交わる径方向に当該本体部201が位置決めされて留置されている。
第1及び第2係合部221、222は、径方向に拡張した状態で、軸方向にほぼ直交するように突出している。これにより、連通部材200の軸方向への抜け止めをより確実に行うことができる。
The main body 201 has a shorter axial length than the main body 1 of the communication member 100 of the above embodiment. Specifically, the length of the main body 201 in the axial direction is slightly longer than the length obtained by adding the walls of the lymphatic vessel L1 and the vein L2. Thereby, it is possible to hold the lymph vessel L1 and the vein L2 in a state where the sides of the vein L2 are almost in contact with each other.
Further, the main body 201 is press-fitted into the through holes L1a and L2a, and the main body 201 is positioned and retained in the axial direction of the main body 201 and in the radial direction intersecting with the axial direction by the expansion force of the main body 201. .
The first and second engaging portions 221 and 222 protrude so as to be substantially orthogonal to the axial direction in a state of being expanded in the radial direction. This makes it possible to more reliably prevent the communication member 200 from coming off in the axial direction.
このように、連通部材200の本体部201は、2つの管腔臓器(例えば、リンパ管L1及び静脈L2)の互いの側部どうしを当接させた状態で、管壁の貫通孔L1a、L2aの各々に挿通される。
したがって、連通部材200により2つの管腔臓器をほぼ密着させた状態で保持することができ、リンパ管L1を流れるリンパ液や静脈L2を流れる血液を漏出させ難くすることができる。
このとき、径方向に拡縮自在に構成された本体部201がリンパ管L1及び静脈L2の管壁の貫通孔L1a、L2aの各々に圧入されることで、当該本体部201を軸方向及び径方向に位置決めして当該連通部材200を留置することができる。
As described above, the main body 201 of the communication member 200 is configured such that the two lumen organs (for example, the lymphatic vessel L1 and the vein L2) are brought into contact with each other, and the through-holes L1a and L2a of the vessel wall are formed. Is inserted through each of the.
Therefore, the two luminal organs can be held in close contact with each other by the communication member 200, and the lymph fluid flowing through the lymphatic vessel L1 and the blood flowing through the vein L2 can be hardly leaked.
At this time, the main body 201, which is configured to be freely expandable and contractible in the radial direction, is press-fitted into each of the through-holes L1a and L2a in the wall of the lymphatic vessel L1 and the vein L2, so that the main body 201 is moved in the axial and radial directions. And the communication member 200 can be detained.
なお、上記実施形態で例示した連通部材100、200の形状や構成は、一例であってこれらに限られるものではなく、2つの管腔臓器(例えば、リンパ管L1及び静脈L2)を連通するものであれば、適宜任意に変更可能である。また、2つの管腔臓器は、リンパ管L1と静脈L2に限られるものではなく、例えば、血管どうしであってもよい。
また、例えば、上記実施形態では、連通部材100(200)として、第1及び第2係合部21、22(221、222)を具備するものを例示したが、一例であってこれに限られるものではなく、本体部201の拡張力等により、軸方向及び径方向に当該本体部201を位置決め可能であれば、必ずしも第1及び第2係合部21、22を具備する必要はない。
Note that the shapes and configurations of the communication members 100 and 200 exemplified in the above embodiment are merely examples, and the present invention is not limited to these, and those communicating two luminal organs (for example, a lymphatic vessel L1 and a vein L2). If so, it can be changed arbitrarily as appropriate. The two luminal organs are not limited to the lymphatic vessel L1 and the vein L2, but may be, for example, blood vessels.
Also, for example, in the above-described embodiment, the communication member 100 (200) is provided with the first and second engagement portions 21 and 22 (221 and 222). However, this is merely an example and is not limited thereto. However, the first and second engaging portions 21 and 22 do not necessarily need to be provided as long as the main body portion 201 can be positioned in the axial direction and the radial direction by the expansion force of the main body portion 201 or the like.
また、上記実施形態では、本体部1を径方向に拡縮自在に構成し、その拡張力により当該本体部1を軸方向及び径方向に位置決めするようにしたが、一例であってこれに限られるものではなく、第1及び第2係合部21、22の拡張力により位置決めするようにしてもよい。このとき、第1及び第2係合部21、22の外面を貫通孔L1a、L2aの各々の軸方向両端部の内面に周方向の全周にわたって当接させた状態とするようにしてもよい。 Further, in the above embodiment, the main body 1 is configured to be able to expand and contract in the radial direction, and the main body 1 is positioned in the axial direction and the radial direction by the expansion force. However, this is only an example and the present invention is limited to this. Instead, the positioning may be performed by the expansion force of the first and second engagement portions 21 and 22. At this time, the outer surfaces of the first and second engaging portions 21 and 22 may be brought into contact with the inner surfaces of both axial ends of the through holes L1a and L2a over the entire circumference in the circumferential direction. .
今回開示された実施の形態はすべての点で例示であって制限的なものではないと考えられるべきである。本発明の範囲は上記した説明ではなくて特許請求の範囲によって示され、特許請求の範囲と均等の意味および範囲内でのすべての変更が含まれることが意図される。 The embodiments disclosed this time are to be considered in all respects as illustrative and not restrictive. The scope of the present invention is defined by the terms of the claims, rather than the description above, and is intended to include any modifications within the scope and meaning equivalent to the terms of the claims.
100、200 連通部材
1、201 本体部
21、221 第1係合部
22、222 第2係合部
L1 リンパ管(第1の管腔臓器)
L2 静脈(第2の管腔臓器)
L1a、L2a 貫通孔
100, 200 Communication member 1, 201 Main body 21, 221 First engaging part 22, 222 Second engaging part L1 Lymph vessel (first luminal organ)
L2 vein (second luminal organ)
L1a, L2a Through-hole
Claims (4)
側部どうしを対向させるように配置された前記2つの管腔臓器の各管壁を貫通するように留置され、
筒状の本体部を有し、
前記本体部の外面を前記管壁の貫通孔の各々の内面に当接させるようにして前記貫通孔の各々に挿通された状態で、前記本体部の軸方向及び前記軸方向と交わる方向に当該本体部が位置決めされて留置可能に構成されている連通部材。 A communication member for communicating the two luminal organs,
Indwelled to penetrate each tube wall of the two luminal organs arranged so that the sides face each other,
It has a cylindrical main body,
In a state where the outer surface of the main body portion is inserted into each of the through holes so as to abut against the inner surface of each of the through holes of the tube wall, the main body portion extends in an axial direction and a direction intersecting with the axial direction. A communication member whose main body is positioned and configured to be able to be placed.
前記貫通孔の各々に挿通された状態で、前記管壁内側面における前記貫通孔の周縁部に前記係合部が係合して、前記軸方向及び前記軸方向と交わる方向に前記本体部が位置決めされる請求項1に記載の連通部材。 It further has an engaging portion provided at both ends in the axial direction of the main body portion and capable of engaging with the inner surface of the tube wall,
In a state inserted into each of the through holes, the engaging portion is engaged with a peripheral portion of the through hole on the inner surface of the tube wall, and the main body portion is disposed in the axial direction and a direction intersecting with the axial direction. The communication member according to claim 1, which is positioned.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018128960 | 2018-07-06 | ||
| JP2018128960 | 2018-07-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2020011058A true JP2020011058A (en) | 2020-01-23 |
Family
ID=69169027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019124120A Pending JP2020011058A (en) | 2018-07-06 | 2019-07-03 | Communication member |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2020011058A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000505316A (en) * | 1996-02-02 | 2000-05-09 | トランスバスキュラー インコーポレイテッド | Method and apparatus for joining openings formed in adjacent blood vessels or other anatomical structures |
| US20170072173A1 (en) * | 2015-09-13 | 2017-03-16 | Treus Legacy Partners, Llc | Inflatable translumenal shunts and methods and devices for delivery |
-
2019
- 2019-07-03 JP JP2019124120A patent/JP2020011058A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000505316A (en) * | 1996-02-02 | 2000-05-09 | トランスバスキュラー インコーポレイテッド | Method and apparatus for joining openings formed in adjacent blood vessels or other anatomical structures |
| US20170072173A1 (en) * | 2015-09-13 | 2017-03-16 | Treus Legacy Partners, Llc | Inflatable translumenal shunts and methods and devices for delivery |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6034492B2 (en) | Instrument and method for limiting anchor penetration depth within an anatomical structure | |
| JP6832111B2 (en) | Stent graft, stent graft set, and stent graft indwelling device | |
| US6334867B1 (en) | Surgical graft/stent system | |
| US8021377B2 (en) | Electroactive polymer actuated medical devices | |
| JP2016512749A5 (en) | ||
| JP2018158233A (en) | Stent device having reduced foreshortening and recoil and method of making the same | |
| JP6389482B2 (en) | Inclined stent | |
| JP2023085467A (en) | Tubular therapeutic device, tubular therapeutic device set and tubular therapeutic device placement device | |
| CN109966016B (en) | Covered stent | |
| JP6081948B2 (en) | Flexible stent | |
| US8690938B2 (en) | Occlusion device combination of stent and mesh with diamond-shaped porosity | |
| JP7434683B2 (en) | stent graft | |
| JP2020011058A (en) | Communication member | |
| WO2021177303A1 (en) | Stent graft and skeleton for stent graft | |
| US11471310B2 (en) | Indwelling device and cylindrical treatment tool | |
| JP2018139792A (en) | Covered stent | |
| EP3207902A1 (en) | Spiral flow inducing stent and cannula cut method of making same | |
| JP6901872B2 (en) | Expansion catheter | |
| EP3103418A1 (en) | Spiral blood flow device with diameter independent helix angle | |
| JP6785146B2 (en) | Blood vessel anastomosis device and indwelling device | |
| JP2005066202A (en) | Flexible stent with excellent blood vessel followability and expandability | |
| JP4835113B2 (en) | Stent | |
| JP2019122556A (en) | Stent | |
| WO2023176909A1 (en) | Deployment device | |
| JP2024136826A (en) | catheter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A625 | Written request for application examination (by other person) |
Free format text: JAPANESE INTERMEDIATE CODE: A625 Effective date: 20220527 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230208 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230221 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230418 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230718 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240130 |